550 research outputs found

    Synthesis and Characterization of Long Acting Darunavir Prodrugs

    Get PDF
    Patient adherence is critical for ART success to ensure adequate viral suppression, therefore, long-acting antiretrovirals are soon replacing current daily regimens. In recent years, two drugs were successfully transformed into long-acting injectables; CAB LA and RPV LA. These long-acting nanoformulations made it possible to abandon the daily pill burden, instead approximately a bimonthly injection of both drugs is enough to suppress and maintain viral load suppression. Our laboratory has been instrumental in transforming FDA-approved and experimental-HIV medications into long-acting slow effective release drugs, also known as LASER ART. LASER ART consists of slow drug metabolism and high permeability and retention inside cellular reservoirs eventually increasing the apparent life of the drugs. In this work, we apply LASER strategies to darunavir, a protease inhibitor (PI). DRV is a preferred PI due to its potency against wild type HIV as well as many mutant resistant viral strains. Among other drugs from its class, DRV is considered to have the highest genetic barrier to HIV mutations. To transform DRV into a LASER DRV, we chemically modified DRV to a prodrug, an inactive form of the drug, by conjugation of different lengths of fatty acids/lipids; M1DRV and M2DRV. These prodrugs were encased in amphiphilic polymer, NM1DRV and NM2DRV, to increase nanoparticles stability and permeability across cell membranes. The prodrug nanoformulations improved uptake, retention, release and antiretroviral activities in macrophages and T cells. Pharmacokinetics studies in mice affirmed the advantage of the modifications in extending the apparent half-life of DRV in animal models. Long-acting DRV offers the option of a long-acting PI that does not require a booster to maintain high concentrations in plasma, blood, and tissues. Therefore, DRV prodrugs nanoformulations can eliminate heavy pill burden and reduce drug-drug interactions that are prominent with PI boosters such as ritonavir and cobicistat

    Marine Fish Farming and the Blue Revolution: Culturing Cod Fisheries

    Get PDF
    The Blue Revolution promises to transform wild marine fish into docile domesticates, fish hunters into harvesters. As commercially fished marine species continue to face extinction in the wild due to overfishing, pollution, global climate change and a host of other anthropogenic assaults, ‘culture’ has emerged as a keyword in the field of marine fisheries management. Like the terrestrial dreams and grandiose visions of their Green comrades a half-century earlier, Blue revolutionaries advocate the application of scientific expertise, industrial technology and trans-national capital in their oceanic culturing projects. These culturing projects influence and seek to transform human identity and ways of living as much as the genetic make-up, behaviours and metabolism of the wild fish species that are targeted for domestication

    Size Resistance to Infection with the Schistosome Parasite in the Vector Snail

    Get PDF
    Schistosomiasis is a parasitic disease that infects 200 million individuals, in mainly undeveloped countries, killing thousands. Schistosoma mansoni is one causative parasite, and it is transmitted by the freshwater snail Biomphalaria glabrata. B. glabrata snails of the BS-90 strain have shown neonatal susceptibility to the parasite, while adults are resistant, although the mechanism is unknown. Here we show that resistance to the parasite may be a function of snail size, since prevalence of infection is lower in larger snails, and since larval parasites (sporocysts) in larger snails have fewer germinal cells, are surrounded by a multilayered capsule of hemocytes, and elicit a strong mitotic response in the snail’s immune tissue. A lower germinal cell count in a sporocyst indicates that the parasite is in an unhealthy physiological state, inasmuch as these are reproductive cells. Additionally, encapsulation signifies that a host response is occurring, as hemocytes surround and constrict the sporocyst. Furthermore, the increase of mitotic figures in the snail immune tissue also suggests a stronger response against the infection in larger snails. Our results demonstrate that snails may develop a more robust immune system as they grow, thereby becoming resistant to infection. Subsequent studies could test for changes in gene expression as a function of size to better understand the mechanism underlying our findings

    Electron ionization mass spectrometry of difurfuryl diamines

    Get PDF
    Electron impact mass spectrometry (ei-ms) has aided the structural characterization of a novel series of synthetic difuranic diamines and permitted the comparison with a previous study employing electrospray ionization mass spectrometry. As expected, the molecular radical ion was inexistant in this series of compounds and the fragmentation routes of the molecular radical ion were governed either by homolytic cleavage of the radical R2• or by heterolytic loss of NH3 to give their respective base peaks

    The role of complement and complement regulators in peripheral nerve and neuromuscular disorders

    Get PDF
    This thesis describes the evaluation of the role of Complement (C) and C regulators (CRegs) in experimental models of peripheral neuropathy and neuromuscular disease. Although a role for C in mediating peripheral neuropathy has previously been demonstrated in Guillain-Barre Syndrome (GBS) and its well characterised animal model Experimnetal Autoimmune Neuritis (EAN), evaluation of the role of individual components is lacking. C activation has also been widely implicated in the pathology seen in myasthenia gravis (MG) and its associated animal model Experimental Autoimmune Myasthenia Gravis (EAMG), although the precise effectors are uncertain. Evaluation of the extent of protection conferred by CRegs in the peripheral nervous system (PNS), and the ability of the myelin-producing Schwann cell to synthesize C components was a vital first step in determining the susceptibility of the system to C attack, and for providing a method of targeting key C-related molecules for further study in vivo. This work demonstrated that the PNS is well protected from membrane attack complex (MAC) attack, with high expression of the terminal pathway regulator, CD59. Crry was also highly expressed, while CD55 had a limited expression, suggesting a possible alternative role for this protein. CD46 was not expressed in the PNS. Testing the susceptibility of C and CReg deficient and knockout animals to induction of EAN and EAMG would enable further clarification of the role of individual C components to disease pathogenesis. For EAN, various antigens derived from myelin protein zero (PO) were generated to induce disease in rodents. Using this panel of antigens, specific, reproducible EAN was not achieved, and the possible reasons for this are discussed. C activation at the neuromuscular junction (NMJ) contributes to pathology in MG, although the precise role of the MAC is undear. EAMG was used to test the susceptibility of wikHype rats versus rats deficient in the terminal pathway component C6, to disease induction. Wildtype rats demonstrated severe weakness following induction of passively transferred EAMG, while C6 deficient rats were completely protected, demonstrated by protection against clinical disease, reduction in acetylcholine receptor (nAChR) loss, absence of inflammatory infiltrates and lack of C9 deposition. Reconstitution of human C6 to the C6 deficient rats resulted in increased disease. Soluble and fusion protein forms of CRegs, and a novel C5 inhibitor were also tested for their ability to abrogate disease in this model. Preliminary studies of EAMG induction in CReg knockout mice revealed that a lack of CD55 and CD59 markedly enhanced disease, although this remains to be confirmed. In conclusion, this work demonstrates: 1 The potential susceptibility of the PNS to C-mediated pathology 2 The difficulties in inducing EAN in rodents using published protocols 3 That MAC is the major drive to NMJ destruction in EAMG CRegs tested in EAMG hold promise for treatment of inflammatory disease, and analysis of the role of CRegs in EAMG in the mouse may shed new light on the precise effectors mediating disease pathogenesis

    Effects of NSTEMI on Patients with Eating Disorders: Insights from the National Inpatient Sample

    Get PDF
    Introduction: Eating disorders (ED) such as bulimia and anorexia nervosa have detrimental implications on the health and wellbeing of children and young adults across the country. Cardiovascular implications are known to accompany these conditions, however there is a paucity of data looking specifically on the effects of NSTEMI on patients with these disorders. We sought to analyze this relationship further by examining these disorders within the national inpatient sample database to describe in-hospital trends and outcomes among those patients. Methods: Data were extracted from the National Inpatient Sample (NIS) Database for the years 2019 and 2020. The NIS was searched for hospitalizations of adult patients with eating disorder(s) with and without a concomitant diagnosis of NSTEMI using international classification of diseases-10th revision codes. Multivariate logistic was used to adjust for confounders. The primary outcome was inpatient mortality. Secondary outcomes were hospital length of stay (LOS), and total hospital charges (TOTHCG). SPSS software was used for statistical analysis. Results: This study included 16,889 patients who were diagnosed with eating disorders, of which only 56 (0.3%) patients were diagnosed with NSTEMI. ED patients with NSTEMI had higher prevalence of hypertension, diabetes mellitus and chronic kidney disease but not statistically different compared to patients with ED only. Multivariate regression showed that patients with both ED and NSTEMI had higher inpatient mortality compared to those with ED alone (OR 1.013, CI 1.011-1.015, p Conclusion: In this nationally representative population‐based retrospective cohort study, we concluded that ED patients hospitalized with NSTEMI have increased in-hospital mortality and worse outcomes. More research is needed in this area
    corecore